Status:
COMPLETED
Gestational Diabetes Follow Up Study
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
Centers for Disease Control and Prevention
Association of American Medical Colleges
Conditions:
Diabetes, Gestational
Postpartum Period
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The primary hypothesis underlying this proposal is that the introduction of a Promotora to provide education and proactive follow-up to women with GDM will increase compliance with postpartum glucose ...
Detailed Description
As Los Angeles County + University of Southern California Medical Center (LAC+USC) serves an indigent Latino population at increased risk for developing Type 2 Diabetes Mellitus (T2DM), Gestational Di...
Eligibility Criteria
Inclusion
- Diagnosed with diabetes for the first time during the most recent pregnancy
- Completed pregnancy \>20 weeks duration
- Has access to a telephone
- Is willing to be contacted by the Promotora
- Is willing to follow-up at LAC+USC for postpartum visit
- Able to give informed consent
- Age ≥18 years
- Residence within 60 miles of LAC+USC
- ON INPATIENT WARD AT LAC+USC AT TIME OF RECRUITMENT
Exclusion
- Diagnosis of diabetes prior to most recent pregnancy (pre-gestational diabetes)
- Current ICU admission during delivery hospitalization that would interfere with recruitment and participation in the study
- Currently residing in jail or inpatient psychiatric facility
- Postpartum day #1-2, any Fasting Blood Glucose ≥126mg/dL or random BG≥200mg/dL
- Plans postpartum follow-up at non-participating postpartum clinic location
- A Medical Record Abstraction Only Cohort is a third group of patients who live within 60 miles of LAC+USC, plan to obtain postpartum care at LAC+USC, and completed a GDM affected pregnancy but refuse participation or do not qualify based on the following: elevated glucose consistent with diagnosis of T2DM or maintained on insulin postpartum, incarceration or resides in inpatient psychiatric facility, age \<18, no telephone, unwilling to be contacted by Promotora, or are unable to consent for participation.This cohort can not be enrolled in the study but data is abstracted from the medical records to compare demographics and follow up in our study to all patients with GDM who deliver at LAC+USC.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT00998595
Start Date
June 1 2009
End Date
October 1 2011
Last Update
March 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles County + University of Southern California Medical Center
Los Angeles, California, United States, 90033